Senzime increases focus on the market for anesthesia monitoring and communicates sales targets
Press release: Uppsala, July 9, 2019. Senzime AB (publ) announces today that the company has chosen to increase its focus on the market for anesthesia monitoring as a result of the increased interest in the company's patient monitor, TetraGraph, which is in a global rollout phase. The company also communicates sales targets for 2019. Senzime develops unique medical technology solutions that aim to reduce complications in connection with operations, with reduced healthcare costs and increased patient benefit as a result. During the spring of 2019, the Board and management carried